ATHE

Alterity Therapeutics
ATHE

Overview Fund Activity

12 hedge funds and large institutions have $149K invested in Alterity Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HWM
1
HB Wealth Management
Georgia
$31.2K
2
UBS Group
2
UBS Group
Switzerland
$16.6K
3
Citadel Advisors
3
Citadel Advisors
Florida
$15.4K
4
BTI
4
Blue Trust Inc
Georgia
$72

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$18.7K
2
Morgan Stanley
2
Morgan Stanley
New York
$58.4K
3
CA
3
CoreCap Advisors
Michigan
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$58.4K 44,501 -3,894 -8%
HWM
2
HB Wealth Management
Georgia
$31.2K 23,783 +23,783 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$18.7K 13,932 -9,379 -40%
UBS Group
4
UBS Group
Switzerland
$16.6K 12,685 +12,683 +634,150%
Citadel Advisors
5
Citadel Advisors
Florida
$15.4K 11,488 +11,488 New
TLCM
6
Twin Lakes Capital Management
California
$7.78K 5,925 – –
PCA
7
Providence Capital Advisors
North Carolina
$263 200 – –
Osaic Holdings
8
Osaic Holdings
Arizona
$105 81 – –
BTI
9
Blue Trust Inc
Georgia
$72 40 +40 New
SWM
10
Sugarloaf Wealth Management
Georgia
$43 33 – –
SPIA
11
Steward Partners Investment Advisory
New York
$8 6 – –
CAS
12
Coppell Advisory Solutions
Texas
$7 5 – –
CA
13
CoreCap Advisors
Michigan
– – -21 Closed
CFGS
14
Concourse Financial Group Securities
Alabama
– – – –